CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 150 enrolled
Drug / intervention
Intravenous ibuprofendrug
Likely dose
Intravenous ibuprofen 400 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01334944
NCT01334944Phase 4Completed
CompareCT.gov

A Multi-Center, Open-Label, Surveillance Trial To Evaluate The Safety and Efficacy of a Shortened Infusion Time of Intravenous Ibuprofen.

Cumberland Pharmaceuticals·interventional·Posted Apr 13, 2011·Updated Jul 5, 2023

In Brief

A Phase 4 clinical trial evaluating Intravenous ibuprofen for Pain and Fever. Completed, enrolled 150 participants across 13 sites.

Detailed Summary

The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the treatment of fever or pain in the hospital setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Fever
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 13, 2011
Enrollment StartJun 1, 2011
Primary CompletionSep 1, 2012
Study CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 15.2 years ago

Interventions

Intravenous ibuprofendrug

400 mg or 800 mg intravenous ibuprofen administered intravenously over 5-10 minutes